| 1 (72) | Hoffmann-La Roche Ltd, United States | USA |  |
| 2 (85) | Genentech Inc | USA | |
| 3 (115) | Pfizer Inc, United States | USA | |
| 4 (122) | Regeneron Pharmaceuticals Inc * | USA | |
| 5 (161) | Bristol-Myers Squibb Company, United States | USA | |
| 6 (179) | Bayer AG, Germany | DEU | |
| 7 (212) | GlaxoSmithKline, United States | USA | |
| 8 (220) | Merck & Co Inc, United States | USA | |
| 9 (227) | Novartis Institutes for Biomedical Research, United States | USA | |
| 10 (232) | AstraZeneca, United Kingdom | GBR | |
| 11 (246) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 12 (285) | Gilead Sciences Inc, United States | USA | |
| 13 (334) | Merck KGaA, Germany | DEU | |
| 14 (347) | Sanofi, France | FRA | |
| 15 (359) | Sanofi, United States | USA | |
| 16 (394) | AbbVie Inc, United States | USA | |
| 17 (403) | Banco Bilbao Vizcaya Argentaria, Spain | ESP | |
| 18 (451) | GlaxoSmithKline, United Kingdom | GBR | |
| 19 (453) | Janssen Research & Development, LLC | BEL | |
| 20 (459) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 21 (480) | AstraZeneca, United States | USA | |
| 22 (482) | Biogen Inc, USA | USA | |
| 23 (539) | Janssen Biotech Inc | USA | |
| 24 (622) | AstraZeneca, Sweden | SWE | |
| 25 (628) | Bosch, Germany | DEU | |
| 26 (646) | Takeda Pharmaceutical Co Inc, Japan | JPN | |
| 27 (673) | Shionogi & Co Ltd | JPN | |
| 28 (679) | CaixaBank SA * | ESP | |
| 29 (685) | Translational Research Institute | AUS | |
| 30 (732) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 31 (780) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 32 (807) | Eli Lilly and Company, United States | USA | |
| 33 (815) | Analysis Group Inc | USA | |
| 34 (822) | Amgen, USA | USA | |
| 35 (947) | Thermo Fisher Scientific, USA | USA | |
| 36 (957) | Sanofi, Germany | DEU | |
| 37 (1033) | Johnson & Johnson, United States | USA | |
| 38 (1108) | RTI International, United States | USA | |
| 39 (1166) | UCB Pharma SA, Belgium | BEL | |
| 40 (1212) | Boehringer Ingelheim GmbH Germany | DEU | |
| 41 (1247) | Novo Nordisk A/S | DNK | |
| 42 (1441) | Unilever, United Kingdom | GBR | |
| 43 (1596) | GlaxoSmithKline, Belgium | BEL | |
| 44 (1727) | Nestle Switzerland | CHE | |
| 45 (1742) | Pfizer Inc, Spain | ESP | |
| 46 (1815) | Novartis, Switzerland | CHE | |
| 47 (1867) | UCB Pharma SA, UK | GBR | |
| 47 (1867) | Daiichi Sankyo Co Ltd, Japan | JPN | |
| 49 (1874) | SINTEF Group * | NOR | |
| 50 (1982) | Pfizer Inc, United Kingdom | GBR | |
| 51 (2000) | Novartis Pharmaceuticals, United States | USA | |
| 52 (2131) | Boehringer Ingelheim, USA | USA | |
| 53 (2453) | Syngenta, United Kingdom | GBR | |
| 54 (2615) | BASF, Germany | DEU | |
| 55 (2865) | RTI Health Solutions, United States | USA | |
| 56 (2895) | IQVIA, United States | USA | |
| 57 (2905) | Procter & Gamble, United States | USA | |
| 58 (3040) | Pharmaceutical Product Development LLC | USA | |
| 59 (3425) | Optum Inc, USA | USA | |
| 60 (3714) | Bayer Corp, USA | USA | |
| 61 (3768) | Ensino Lusofona * | PRT | |
|
